Literature DB >> 15170527

Retransplantation of the liver in adults: outcome and predictive factors for survival.

Renske Postma1, Elizabeth B Haagsma, Paul M J G Peeters, Aad P van den Berg, Maarten J H Slooff.   

Abstract

Hepatic retransplantation is considered to carry a higher risk than primary transplantation. Survival might improve with more experience and better immunosuppression. We studied all 55 patients who were adults at the time of their first retransplantation and who underwent retransplantation between 1979 and May 2001. Patient survival at 1, 5 and 10 years was 73%, 63%, and 63%, respectively. Multivariate analysis of pre-transplant variables revealed prothrombin time, creatinine level, and indication for retransplantation, as independent predictive factors. Survival was highest in patients who had undergone retransplantation for hepatic artery thrombosis. Multivariate analysis, including pre-, per-, and post-operative variables, showed that era of transplantation, prothrombin time, blood loss, and intensive care unit (ICU) stay, were independent predictive factors. Survival at 1 and 5 years improved from 56% and 48%, respectively, before 1996 to 89% and 81%, respectively, after 1996. In conclusion, survival after hepatic retransplantation improved significantly through the years. Independent pre-transplant predictive factors were prothrombin time, creatinine level, and indication for retransplantation. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15170527     DOI: 10.1007/s00147-004-0708-5

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Liver retransplantation in adults: a single-centre, 25-year experience.

Authors:  Ravi Marudanayagam; Vivekanandan Shanmugam; Bynvant Sandhu; Bridget K Gunson; Darius F Mirza; David Mayer; John Buckels; Simon R Bramhall
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

Review 2.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

Authors:  Bjarte Fosby; Tom H Karlsen; Espen Melum
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

3.  Short- and long-term outcomes of third liver transplantation at single centre.

Authors:  Hideya Kamei; Mamoun Al-Basheer; Jeffrey Shum; Michael Bloch; Roberto Hernandez Alejandro; Vivian McAlister; William Wall; Douglas Quan
Journal:  Hepatol Int       Date:  2012-03-14       Impact factor: 6.047

4.  Significant influence of the primary liver disease on the outcomes of hepatic retransplantation.

Authors:  A Qasim; B M Zaman; J Geoghegan; D Maguire; O Traynor; J Hegarty; P A McCormick
Journal:  Ir J Med Sci       Date:  2008-11-04       Impact factor: 1.568

Review 5.  Liver retransplantation for adult recipients.

Authors:  Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2013-02-28

6.  Posttransplant muscle mass measured by urinary creatinine excretion rate predicts long-term outcomes after liver transplantation.

Authors:  Suzanne P Stam; Maryse C J Osté; Michele F Eisenga; Hans Blokzijl; Aad P van den Berg; Stephan J L Bakker; Vincent E de Meijer
Journal:  Am J Transplant       Date:  2018-06-03       Impact factor: 8.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.